Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03880955 · ClinicalTrials.gov registry record
A Post-Market Clinical Evaluation of the ReUnion Reverse Shoulder Arthroplasty (RSA) System
A clinical trial, sponsored by Stryker Trauma and Extremities.
- Terminated
- Registry status
- 102
- Enrollment target
NCT03880955 is a clinical trial that was terminated before completion, run by Stryker Trauma and Extremities. The registered enrollment target is 102 participants.
The verdict
NCT03880955 was terminated before completion, sponsored by Stryker Trauma and Extremities.
- TERMINATED
- Registry status
- 102 participants
- Enrollment target
Study Summary
This investigation is a prospective, multicenter clinical investigation. It is anticipated that a total of eighty (80) subjects will be enrolled at approximately 4-7 sites. The clinical investigation has been designed to follow the surgeon's standard of care for joint arthroplasty subjects, which entails clinical evaluation on a regular ongoing basis, or as needed should the subject become symptomatic in the treated joint.
Interventions
- DEVICE ReUnion RSA System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2019-06-25 |
| Est. Completion | 2023-12-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03880955
The ClinicalTrials.gov registry entry for NCT03880955 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Trauma and Extremities, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ReUnion RSA System is the first listed.
NCT03880955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03880955 about?
NCT03880955 is a clinical study titled "A Post-Market Clinical Evaluation of the ReUnion Reverse Shoulder Arthroplasty (RSA) System". This investigation is a prospective, multicenter clinical investigation. It is anticipated that a total of eighty (80) subjects will be enrolled at approximately 4-7 sites. The clinical investigation has been designed to follow the surgeon's standard of care for joint arthroplasty subjects, which en...
What is the current status of trial NCT03880955?
This trial is currently terminated. The enrollment target is 102 participants. The study started on 2019-06-25. Estimated completion is 2023-12-13.
What interventions are being tested in trial NCT03880955?
The interventions under investigation include: ReUnion RSA System (DEVICE).
Who is sponsoring clinical trial NCT03880955?
This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.